Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19

By afschroeder • February 4, 2026

Ma KC, Webber A, Lauring AS, Bendall E, Papalambros LK, Safdar B, Ginde AA, Peltan ID, Brown SM, Gaglani M, Ghamande S, Columbus C, Mohr NM, Gibbs KW, Hager DN, Prekker ME, Gong MN, Mohamed A, Johnson NJ, Khan A, Hough CL, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Busse LW, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Mosier JM, Leis AM, Harris ES, Baughman A, Cornelison SA, Blair PW, Johnson CA, Lewis NM, Ellington S, Rice TW, Grijalva CG, Talbot HK, Casey JD, Halasa N, Chappell JD, Zhu Y, Self WH, Dawood FS, Surie D; Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19. JAMA Netw Open. 2026 Feb 2;9(2):e2557415. doi: 10.1001/jamanetworkopen.2025.57415. PMID: 41632473.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Place Security and Mental Health: Two Sides of the Same Coin Among Young Adults with Perinatally-Acquired HIV and Exposure in New York City

Kang E, Mellins CA, Kim W, Dolezal C, Quick P, Reyes V, Emerenciano H, Poku OB, Kluisza L, Hosaka KRJ, Robbins R, Abrams EJ. Place[...]

Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement

Rockwell MS, Kahn KL, Fendrick AM, Vangala S, Mafi JN. Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement. JAMA Netw Open. 2026 May 1;9(5):e2616780. doi: 10.1001/jamanetworkopen.2026.16780. PMID: 42118539.

Comparing Phenotypic Susceptibility Profiles of Neisseria gonorrhoeae for Tetracycline and Doxycycline

Liu L, Branda JA, Azzato F, Klausner JD, Kersh EN, Pasricha S, Allan-Blitz LT. Comparing Phenotypic Susceptibility Profiles of Neisseria gonorrhoeae for Tetracycline and Doxycycline.[...]